Evaluation of cancer-related c-terminal variants provides evidence of the existence of a complex allosteric node at the c-terminus of c-Src controlling the crosstalk between substrate- and enzyme-acting kinases, and how perturbation of this allosteric phospho-switch may drive c-Src dysfunction in cancer. This evidence concerns the gene SRC and cancer.